Article Details

AstraZeneca Gets CDSCO Panel Nod To study Tezepelumab - Medical Dialogues

Retrieved on: 2025-04-13 18:23:44

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Gets CDSCO Panel Nod To study Tezepelumab - Medical Dialogues. View article details on hiswai:

Excerpt

New Delhi: Pharmaceutical major AstraZeneca Pharma India has got approval from the Subject Expert Committee (SEC) functional under the Central ...

Article found on: medicaldialogues.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo